With the improvement of people’s living standards, medical checkups have become an annual necessity for many people, and with them, various diseases that do not easily cause discomfort have entered people’s view, of which hepatic hemangioma is a typical representative. Hepatic hemangiomas are the most common benign tumors of the liver, occurring between the ages of 30 and 50, and are more common in women. Hepatic hemangiomas usually occur in childhood and are found during adult physical examinations and are usually solitary, or in a few cases, multiple. Hepatic hemangiomas are usually asymptomatic, especially when they are smaller. When the partial hepatic hemangioma is larger or grows to the edge of the liver, symptoms such as persistent vague abdominal pain, fullness after meals, indigestion, etc. may occur, and can be life-threatening if it ruptures and bleeds spontaneously or if external impact causes bleeding. In daily life, hepatic hemangioma should be a disease that people both love and hate. Why do you say love it? Because it is difficult to distinguish hepatic hemangioma from liver cancer in general physical examination, maybe ultrasound can only detect tumor in the liver, but it is not easy to distinguish benign or malignant, which makes people worried; and after further examination, the moment we get the result, the report shows that it is hepatic hemangioma, not liver cancer, at this time anxious heart can finally return to normal! At this moment, I think I should love it to death! And then came the problem: should we treat it? How to treat it? The doctor may tell you that it is benign, don’t worry, but be careful not to break it or be careful when you fall down, it will kill you if it bleeds. Yes, but there are risks associated with surgery, such as… And so on a series of, think at this time the mood and instantly fell to the bottom, should hate it! Indeed, liver hemangioma through drug treatment is almost ineffective, the traditional method is surgery, but because of the high risk of surgery, long post-operative recovery time and relatively large trauma to the body, it has become the biggest heartache of patients suffering from liver hemangioma: surgery is so risky, there is no discomfort now, in case there are any complications from surgery, it is not a big loss? In fact, in recent years, the minimally invasive treatment of hepatic hemangioma has developed very rapidly, and the representative interventional treatment of hepatic hemangioma has been gradually promoted and applied, and it can be carried out skillfully in many tertiary hospitals in China, and now it has become one of the common clinical treatment methods. Interventional treatment of hepatic hemangioma is mainly divided into two kinds, one is selective hepatic artery embolization, and the other is direct percutaneous puncture sclerotherapy and drug injection. Selective hepatic artery embolization refers to piercing a rice-sized opening with a needle in the femoral artery, and then operating a catheter through it to the blood supply artery of hepatic hemangioma, and then embolizing the blood supply vessel while injecting drugs into the hepatic hemangioma through the catheter, because the drugs can inhibit and destroy the endothelial cells of blood vessels, and then embolizing the blood supply artery, the abnormal sinus thrombus formation of hepatic hemangioma can be mechanized, so that the tumor can shrink and achieve the purpose of treatment. The purpose of treatment is to reduce the size of the tumor. Direct percutaneous puncture percutaneous puncture sclerotherapy and drug injection treatment is to insert a needle directly into the hepatic hemangioma under the guidance of B ultrasound or CT, and then inject sclerosing agent directly into the tumor, which will dehydrate and fix the tumor tissue, coagulate and denature the cellular proteins, resulting in necrosis of the tumor, fibrosis and slow shrinkage and absorption, so as to achieve the treatment purpose. The most important features of these two types of interventional minimally invasive treatment for liver hemangioma are: small trauma: the small puncture opening only needs to be disinfected, and then a band-aid is applied to it, no need to change medication or anti-inflammatory drugs; small impact on liver function: nowadays, with the development of microcatheters and other interventional materials, liver function is sometimes basically not damaged, or only a little bit damaged, and it recovers in a few days; short hospitalization days: I think no one wants to stay in the hospital for a few more days. hospital for a few more days, and both methods can achieve this goal. A few days of postoperative liver protection drugs are usually sufficient, and the patient can be discharged soon. Low risk: Both techniques are relatively mature and are routinely performed in many tertiary care hospitals, with very low risk. To put it in layman’s terms, if you want open surgery for hepatic hemangioma, you probably have to find a senior, fairly experienced chief of surgery to do it, whereas if it’s an intervention, then you’re looking for a generally responsible attending physician! Of course, hepatic hemangioma is a benign tumor, not all of which must be treated. Treatment can be considered in the following cases: 1) if the hepatic hemangioma is larger than 5 cm and has obvious pressure symptoms or pain; 2) if the hepatic hemangioma is adjacent to the liver envelope and has the risk of rupture; 3) if the hepatic hemangioma has ruptured and bleeding (this must be done, interventional embolization is very effective in stopping bleeding); 4) if the hepatic hemangioma cannot be removed openly or is unwilling to receive open treatment; 5) if the hepatic hemangioma is found to increase rapidly for a short time during regular review.